DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 104 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $113,000 | -48.4% | 5,581 | -5.1% | 0.05% | -44.4% |
| Q2 2021 | $219,000 | -29.6% | 5,880 | -51.6% | 0.09% | -31.3% |
| Q1 2021 | $311,000 | +18.3% | 12,152 | +1.8% | 0.13% | +20.2% |
| Q4 2020 | $263,000 | -4.7% | 11,939 | -22.3% | 0.11% | -24.8% |
| Q3 2020 | $276,000 | -37.8% | 15,364 | -12.0% | 0.14% | -31.0% |
| Q2 2020 | $444,000 | +79.8% | 17,461 | +30.0% | 0.21% | +105.9% |
| Q1 2020 | $247,000 | -27.1% | 13,430 | -12.6% | 0.10% | +85.5% |
| Q4 2019 | $339,000 | +37.8% | 15,371 | -10.2% | 0.06% | +10.0% |
| Q3 2019 | $246,000 | -13.7% | 17,115 | -5.3% | 0.05% | -16.7% |
| Q2 2019 | $285,000 | +9.2% | 18,068 | -26.1% | 0.06% | +33.3% |
| Q4 2018 | $261,000 | – | 24,457 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |